Veeva Systems Inc. (NYSE:VEEV - Get Free Report) insider Thomas Schwenger sold 10,000 shares of Veeva Systems stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the sale, the insider directly owned 19,449 shares in the company, valued at approximately $5,471,587.17. This represents a 33.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Veeva Systems Stock Up 3.2%
Veeva Systems stock opened at $285.56 on Tuesday. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50. The firm has a 50 day moving average price of $211.13 and a 200-day moving average price of $185.08. The company has a market capitalization of $46.39 billion, a P/E ratio of 46.97, a P/E/G ratio of 1.19 and a beta of 0.92.
Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.12. The company had revenue of $927.96 million during the quarter, compared to analyst estimates of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. Veeva Systems's quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Equities analysts expect that Veeva Systems Inc. will post 6.65 EPS for the current fiscal year.
Institutional Investors Weigh In On Veeva Systems
Institutional investors have recently made changes to their positions in the stock. SHP Wealth Management bought a new position in shares of Veeva Systems in the fourth quarter worth $26,000. Compass Financial Management LLC bought a new stake in shares of Veeva Systems during the 2nd quarter valued at $27,000. Arlington Trust Co LLC purchased a new stake in Veeva Systems during the 2nd quarter worth about $29,000. Field & Main Bank purchased a new stake in Veeva Systems during the 2nd quarter worth about $29,000. Finally, MV Capital Management Inc. bought a new position in Veeva Systems in the 4th quarter worth about $30,000. Hedge funds and other institutional investors own 88.20% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. BNP Paribas Exane restated an "outperform" rating and issued a $285.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. TD Cowen increased their price target on Veeva Systems from $235.00 to $283.00 and gave the stock a "buy" rating in a research note on Monday, August 24th. Zacks Research lowered Veeva Systems from a "strong-buy" rating to a "hold" rating in a report on Thursday, May 14th. Royal Bank Of Canada boosted their price objective on Veeva Systems from $275.00 to $325.00 and gave the company an "outperform" rating in a research note on Thursday, August 27th. Finally, Mizuho upped their price objective on shares of Veeva Systems from $270.00 to $280.00 and gave the company an "outperform" rating in a report on Thursday, August 27th. Nineteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $284.46.
View Our Latest Research Report on Veeva Systems
Veeva Systems Company Profile
(
Get Free Report)
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
